醫藥組合物及於製備治療癌症藥物之用途與評估方法

Translated title of the contribution: Pharmaceutical composition, usage and evaluation method to prepare medicines to cure cancer

Chia-Yu Yang (Inventor), Kai-Ping Chang (Inventor), Chih-Ching Wu (Inventor), QIAO-ROU LIU (Inventor), JUN-NAN OUYANG (Inventor), JIA-XUN XIE (Inventor)

Research output: Patent

Abstract

The disclosure of the present invention relates to an evaluation method used to determine whether an individual suffering from cancer is suitable to use a pharmaceutical composition as a cancer drug. By comparing expression levels of target genes (CHEK1 and PIK3CA) with basic multiples, the individuals suffering from cancer (CHEK1 high performance and PIK3CA high performance) suitable for the use of the pharmaceutical composition are found. Furthermore, it is recommended to use this pharmaceutical composition (cell checkpoint kinase (CHK1) inhibitor and phosphoinositide 3-kinase (PI3K) inhibitor) to inhibit a survival ability and a tumor growth ability of cancer cells to achieve the treatment of cancer.
Translated title of the contributionPharmaceutical composition, usage and evaluation method to prepare medicines to cure cancer
Original languageChinese (Traditional)
IPCA61K 35/00(2006.01); A61P 35/00(2006.01); C12Q 1/6809(2018.01)
StatePublished - 16 07 2021

Bibliographical note

公開公告號: 2.02126818E8
Announcement ID: 2.02126818E8

Fingerprint

Dive into the research topics of 'Pharmaceutical composition, usage and evaluation method to prepare medicines to cure cancer'. Together they form a unique fingerprint.

Cite this